Cargando…

The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia

Hairy cell leukemia (HCL) is a chronic lymphoproliferative B-cell disorder where the B-RAF V600E mutation has been recently detected, as reported for solid neoplasias but not for other B-cell lymphomas. The digital droplet PCR (dd-PCR) is a molecular technique that, without standard references, is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guerrini, Francesca, Paolicchi, Matteo, Ghio, Francesco, Ciabatti, Elena, Grassi, Susanna, Salehzadeh, Serena, Ercolano, Giacomo, Metelli, Maria R., Del Re, Marzia, Iovino, Lorenzo, Petrini, Iacopo, Carulli, Giovanni, Cecconi, Nadia, Rousseau, Martina, Cervetti, Giulia, Galimberti, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061817/ https://www.ncbi.nlm.nih.gov/pubmed/27790140 http://dx.doi.org/10.3389/fphar.2016.00363

Ejemplares similares

The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study
por: Galimberti, Sara, et al.
Publicado: (2017)

Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia Patients
por: Grassi, Susanna, et al.
Publicado: (2020)

Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia
por: Martini, Francesca, et al.
Publicado: (2019)

The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients
por: Salehzadeh, Serena, et al.
Publicado: (2019)

The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice
por: Galimberti, Sara, et al.
Publicado: (2019)

The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia
por: Grassi, Susanna, et al.
Publicado: (2019)

Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup
por: Ciabatti, Elena, et al.
Publicado: (2017)

Safety and Efficacy of Rituximab and Cyclophosphamide in a Case of Resistant Acquired Hemophilia A in Course of Chronic Lymphocytic Leukemia
por: Mazziotta, Francesco, et al.
Publicado: (2019)

Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool
por: Galimberti, Sara, et al.
Publicado: (2022)

Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation
por: Ricci, Federica, et al.
Publicado: (2020)

BRAF V600E-Negative Hairy Cell Leukaemia
por: Langabeer, Stephen E., et al.
Publicado: (2013)

The mechanism of activation of monomeric B-Raf V600E
por: Maloney, Ryan C., et al.
Publicado: (2021)

Large granular lymphocytes (LGL) in primary Sjögren syndrome (pSS): immunophenotype and review on the pathological role of T cells in pSS
por: Tavarozzi, Rita, et al.
Publicado: (2020)

Activation mechanisms of clinically distinct B‐Raf V600E and V600K mutants
por: Zhang, Mingzhen, et al.
Publicado: (2022)

Simultaneous presentation of plasma cell myeloma and hairy cell leukemia
por: Carulli, Giovanni, et al.
Publicado: (2019)

Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation
por: Zaharie, Florin, et al.
Publicado: (2015)

The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia
por: Galimberti, Sara, et al.
Publicado: (2018)

Suppression of B-Raf(V600E) cancers by MAPK hyper-activation
por: Atiq, Rawan, et al.
Publicado: (2016)

Melanoma whole exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance
por: Shi, Hubing, et al.
Publicado: (2012)

BRAF V600E Mutation in Multiple Primary Malignancies: A Hairy Affair
por: White, Richard, et al.
Publicado: (2018)

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
por: Poulikakos, Poulikos I., et al.
Publicado: (2011)

Novel natural inhibitors targeting B-RAF(V600E) by computational study
por: Wu, Bo, et al.
Publicado: (2021)

Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: a case report
por: Carulli, Giovanni, et al.
Publicado: (2011)

Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results
por: Fazzi, Rita, et al.
Publicado: (2021)

Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2
por: Galimberti, Sara, et al.
Publicado: (2020)

A Look Inside of the Complex Pathogenesis of B-RAF(V600E)-Driven Cancer
por: Caputo, Emilia
Publicado: (2017)

Discovery of New Quinolone-Based Diarylamides as Potent B-RAF(V600E)/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity
por: Kim, Hyun Ji, et al.
Publicado: (2023)

Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study
por: Galimberti, Sara, et al.
Publicado: (2012)

Hairy cell leukemia with CCND1/IGH fusion gene and BRAF V600E mutation
por: Rahman, Zaid Abdel, et al.
Publicado: (2020)

Analysis of the B-RAF(V600E) mutation in cutaneous melanoma patients with occupational sun exposure
por: CANDIDO, SAVERIO, et al.
Publicado: (2014)

Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAF(V600E)-Mutant Human Glioma
por: Schreck, Karisa C., et al.
Publicado: (2021)

Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia
por: Broccoli, Alessandro, et al.
Publicado: (2021)

Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells
por: Molnár, Eszter, et al.
Publicado: (2018)

Discrepant Results for BRAF V600E Mutation Among Different Specimens in a Case of Hairy Cell Leukemia
por: Moon, Hee-Won, et al.
Publicado: (2013)

BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia
por: Broccoli, Alessandro, et al.
Publicado: (2019)

Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation–positive hairy cell leukemia
por: Kreitman, Robert J., et al.
Publicado: (2023)

Apoptosis of human melanoma cells induced by inhibition of B-RAF(V600E) involves preferential splicing of bim(S)
por: Jiang, C C, et al.
Publicado: (2010)

Differential sensitivity of melanoma cell lines with BRAF(V600E )mutation to the specific Raf inhibitor PLX4032
por: Søndergaard, Jonas N, et al.
Publicado: (2010)

B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1
por: Choi, Yong Won, et al.
Publicado: (2014)

BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition
por: Obasaju, Patience, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_elul2ldvhiht6juraj3edl6v1t